Biomakers Raises $8 Million to Fuel Global Expansion of Precision Oncology Platform
“Biomakers, a San Francisco-based precision medicine company, has secured an additional $8 million in funding to scale its AI-native oncology intelligence platform, which integrates molecular diagnostics, a vast tumor biobank, and real-world clinical data to accelerate drug development and improve patient outcomes in underserved regions like Latin America.” In the rapidly evolving landscape of biotech … Read more